Search

everythinglearnresearchcommunity

for

Search:↓

Androgen use may increase the risk of stroke, but more research is needed.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Magnetized saline water lotion increased hair growth in men with hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Combining supplements with minoxidil improves hair growth more than minoxidil alone.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.